Authors

Advances allow for more accurate detection of metastatic disease.

Inga Shugalo

Latest Article

Medical software should be chosen based on your practice’s life cycle stage

At each stage, health care providers have different priorities and goals, and the choice of medical software solutions should be made accordingly.

Daniel E. Spratt, MD

Latest Article

The current state of adjuvant radiotherapy post prostatectomy: 3 take-home messages

"If your practice does not closely monitor patients and send them for early salvage radiotherapy when their PSA is 0.1 or 0.2 ng/mL, it is likely that adjuvant radiotherapy is superior," Daniel E. Spratt, MD, writes.

Peter Fioramonti, BS

Fioramonti is a clinical research assistant with Associated Medical Professionals in Syracuse, New York.

Latest Article

Presentation, diagnosis, and management of a rare case of urachal adenocarcinoma

"Urachal carcinoma is a rare and aggressive malignancy. The low incidence of the disease results in limited large-scale clinical trials that could provide standardized guidelines for its diagnosis and management," write Christopher Pieczonka, MD, and Peter Fioramonti, BS.

Danielle Ternyila

Latest Article

Subgroup data sustain enzalutamide PFS benefit in nmCRPC

No new safety signals were reported with the androgen receptor pathway inhibitor.

Emory Urology

Latest Article

New study uncovers how prostate cancer becomes deadly and offers hope for new treatments

4 months ago

A first-of-its kind study led by Emory researchers uncovered how prostate cancer transforms into its most lethal form — and identified a promising new treatment strategy.

Ricardo Soares, MD

Dr. Soares is a urologist with Northwestern Medicine in Chicago (Western suburbs), Illinois.

Latest Article

Minimizing incontinence after radical prostatectomy: Lessons learned

Jesse D. Bracamonte, DO, FAAFP

"I've worked in 3 different countries, I've seen dozens of people doing robotic radical prostatectomy...so my current practice is kind of a “best of” what I have seen and learned," says Ricardo Soares, MD.

Latest Article

Physician Commentary: Do EHR upgrades really enhance patient care?

"Clinicians, now more than ever, have many data entry duties. The clinical encounter’s efficiency is dictated by the ease of the EHR," write Jesse D. Bracamonte, DO, FAAFP, and Michael Underhill, DO.

Joelle Hamilton, MD

Latest Article

Case review: An incidentally discovered renal mass

An expert panel discusses the case of a 65-year-old Caucasian male who is noted to have an incidental 3-cm right renal mass, enhancing on a contrasted CT scan as part of a routine follow-up for his metastatic castration-resistant prostate cancer, diagnosed in 2017 and currently undergoing therapy.

Tim Kostner

Latest Article

Expert explains how to fully optimize EHRs

Recent advances in technology make it possible to access and harness the vast amounts of clinical data EHRs have produced.

Ryan McDonald

Latest Article

Exploratory analysis identifies blood-based biomarkers that may predict treatment outcomes in urothelial carcinoma

The exploratory analysis may have showcased the benefit of testing for tertiary lymphoid structures.

Lindsay Fischer

Latest Article

Front-line maintenance with avelumab found efficacious for locally advanced, metastatic mUC

The real-world data were presented at the 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium.

Jason Harris

Latest Article

Expert highlights the latest radiotherapy developments in prostate cancer

“As the ability to target improved, what we really clearly saw was the idea that perhaps a treatment course could be shortened significantly, and that the term hypofractionation became commonly applied to men with prostate cancer,” said Walter J. Curran Jr, MD, FACR, FASCO.

Caitlin Delaney, MD

Latest Article

Physician Burnout: Assessing and addressing its impact on your family

“A physician struggling under an unbearable weight of emotions, or going to work feeling like they are enduring emotional trauma can have trickle down emotional effects on family members,” writes physician and US Navy veteran Caitlin Delaney, MD.

Silas Inman

Latest Article

Capivasertib prolongs rPFS in PTEN-deficient hormone-sensitive prostate cancer

2 months ago

"The primary end point was met, showing a statistically significant rPFS benefit with the combination of capivasertib and abiraterone," said Karim Fizazi, MD, PhD.

Amanda Wager, Esq

Latest Article

Malpractice Consult: Affidavits of merit and why they matter

Most states require affidavits for malpractice cases to proceed.

Christine Van Horn, MD

Latest Article

Quiz: Testicular trauma in 21-year-old

A 21-year-old male presented to the emergency department for evaluation of testicular pain and swelling 5 days after being struck in the groin.

Mark Schuster, MD, PhD

Latest Article

Expert emphasizes significance of physician self-care

Urology Times contributor

If you’re a doctor, your job is to take care of others. But too often, that comes at the expense of taking care of yourself.

Latest Article

A urologist on why the time is right to let go

"It is the right time and I have been fortunate to have such great people to work with locally and nationally," a urologist writes.

Lisa F. Newcomb, PhD

Latest Article

Lisa F. Newcomb, PhD, on active surveillance for prostate cancer

a year ago

"My hope is that the results of our study improve the uptake of active surveillance, further reducing unnecessary treatments, and this, combined with the improving reflex tests, may change the risk-benefit of PSA screening," says Lisa F. Newcomb, PhD.

Jaret Shook

Latest Article

PARP inhibitors: Treating mCRPC from a genetic basis

Treatments provide a targeted therapeutic strategy for metastatic castration-resistant prostate cancer.

Tony Berberabe, MPH

Latest Article

Extended lymphadenectomy yields no additional benefit vs standard procedure for urothelial cancer

Extended lymph node dissection during radical cystectomy offered no additional overall survival or disease-free survival benefit vs standard lymph node dissection.

Jeremy D. Handel, MD

Latest Article

Case review: An incidentally discovered renal mass

Morgan Bayer

Latest Article

2-year data show continued enfortumab vedotin efficacy in cisplatin-ineligible MIBC

Updated findings from cohort H of the EV-103 study showed promising 2-year event-free survival outcomes and favorable antitumor activity with enfortumab vedotin in cisplatin-ineligible patients with muscle-invasive bladder cancer.

Hayley Virgil

Latest Article

Olaparib plus abiraterone/prednisone linked with improved PFS in mCRPC

The median PFS was 39 months (95% CI, 22-not reached [NR]) in arm 3 compared with 8.4 months (95% CI, 2.9-17.0) in arm 1 and 14 months (95% CI, 8.4-20.0) in arm 2.

Sabrina Serani

Latest Article

Apalutamide combo hits high 2-year RFS rate in prostate cancer

Stephanie Gleicher, MD, MPH

Treatment with apalutamide and androgen deprivation therapy led to a 2-year biochemical recurrence-free survival rate of 100% in patients with high-risk, post-prostatectomy prostate cancer.

Allegheny Health Network

Latest Article

AHN Offering Advanced Urological Care Close to Home for Patients in Erie

6 months ago

The recent expansion of AHN Saint Vincent Allied Urology was purposefully designed to enhance every aspect of the patient experience.

Gleicher is a fellow in female pelvic medicine and reconstructive urology at Vanderbilt University Medical Center in Nashville, Tennessee.

Latest Article

The status and future direction of advanced urine testing: multiplex PCR

"Given that PCR testing may have a benefit for specific cohorts, it is recommended that more clinical evidence be provided to better guide Medicare in defining 'medical necessity,' ” write Stephanie Gleicher, MD, MPH, and Roger R. Dmochowski MD, MMHC, FACS.

Bob Kronemyer

Latest Article

Dr. Cheryl Iglesia highlights the evolving treatment paradigm for overactive bladder